- PAVmed press release (NASDAQ:PAVM): Q4 Non-GAAP EPS of -$0.15 beats by $0.04.
- Revenue of $112M (-62.7% Y/Y) beats by $111.32M.
- PAVmed had cash and cash equivalents of $39.7 million as of December 31, 2022, compared with $77.3 million as of December 31, 2021.